1232 completed, 396 active not recruiting, 336 recruiting, 81 terminated. 808 Phase 2, 480 Phase 1, 345 Not applicable, 85 Phase 3, 40 Early Phase 1.
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Strategies to Decentralize Breast Ultrasound in Rwanda Teleultrasound with Philips Lumify ultrasound probes and Reacts software, Asynchronous virtual feedback - Breast Cancer, Early Detection of Cancer | Not applicable | Not yet recruiting | Brigham and Women's Hospital | 1792 | 2027-01-01 | 2026-06-02 |
| A Study of Ropeg-Interferon in People With Polycythemia Vera Ropeginterferon - Polycythemia Vera (PV), JAK2 Mutation | Phase 2 | Not yet recruiting | Memorial Sloan Kettering Cancer Center | 55 | 2026-10-30 | 2026-10-21 |
| CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin Lymphoma CD30+ CAR T-cells, Bendamustin, Fludarabine - Classical Hodgkin Lymphoma | Phase 1 | Not yet recruiting | New York Medical College | 12 | 2026-10-01 | 2026-05-20 |
| A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer Fam-Trastuzumab Deruxtecan-Nxki - Colorectal Cancer, Adenocarcinoma of the Colon | Phase 2 | Not yet recruiting | Memorial Sloan Kettering Cancer Center | 27 | 2026-10-01 | 2026-10-01 |
| Study of Vaping Use Among Adolescent and Young Adult Patients With Cancer Study assessments - Cancer, Vaping | Enrolling by invitation | Memorial Sloan Kettering Cancer Center | 80 | 2026-09-30 | 2026-10-16 | |
| Improving Goals of Care Conversations Between Doctors and Young Adults With Cancer Jumpstart GOCC intervention - Cancer | Not applicable | Enrolling by invitation | Memorial Sloan Kettering Cancer Center | 118 | 2026-09-25 | 2026-10-08 |
| A Study of Treatment Delivery Preference In People With Kidney Cancer Nivolumab Injectable Product, Nivolumab, Pembrolizumab injection - Renal Cell Carcinoma, Kidney Cancer | Phase 4 | Recruiting | Memorial Sloan Kettering Cancer Center | 40 | 2026-09-24 | 2026-10-16 |
| Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Adult Burkitt Lymphoma | Phase 2 | Not yet recruiting | AIDS Malignancy Consortium | 43 | 2026-09-17 | 2026-10-16 |
| A Study of Ear Nerve Stimulation to Treat Eye Inflammation Cymbathera One System - Ocular Inflammation, Crystalline Lens; Chalcosis | Phase 1 | Recruiting | Memorial Sloan Kettering Cancer Center | 20 | 2026-09-09 | 2026-09-21 |
| A Study of Music Therapy for Anxiety in People With Cancer AI-Assisted Collaborative Songwriting (ARTIST) Intervention, Time and attention matched-music listening (TAME) - Cancer | Not applicable | Recruiting | Memorial Sloan Kettering Cancer Center | 240 | 2026-09-04 | 2026-10-14 |
| A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma Intratumoral 2141-V11, Nivolumab, Fluoropyrimidine - Esophageal Cancer, Advanced Esophageal Cancer | Phase 1 / Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 30 | 2026-09-04 | 2026-09-14 |
| A Study of SX-682 in Combination With Proton Craniospinal Irradiation (pCSI) in People With Leptomeningeal Disease SX-682, Proton Craniospinal Irradiation (pCSI) - Leptomeningeal Disease (LMD) | Phase 1 | Recruiting | Memorial Sloan Kettering Cancer Center | 40 | 2026-09-04 | 2026-09-11 |
| A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia Blinatumomab Injection - B-cell Acute Lymphoblastic Leukemia, B-Cell Acute Lymphoblastic Leukemia, Adult | Phase 1 / Phase 2 | Not yet recruiting | Memorial Sloan Kettering Cancer Center | 26 | 2026-09-01 | 2026-08-11 |
| A Study of Zanubrutinib, Obinutuzumab, and Sonrotoclax in People With Mantle Cell Lymphoma Zanubrutinib, Obinutuzumab, Sonrotoclax - Mantle Cell Lymphoma | Phase 2 | Not yet recruiting | Memorial Sloan Kettering Cancer Center | 45 | 2026-09-01 | 2026-09-10 |
| A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma Cemiplimab, Fianlimab - Nasopharyngeal Carcinoma, Nasopharyngeal Cancer | Phase 1 | Not yet recruiting | Memorial Sloan Kettering Cancer Center | 60 | 2026-09-01 | 2026-08-11 |
| A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate PET/CT, 177Lu-DTPA-SC16.56 - Neuroendocrine Tumor of the Lung, Neuroendocrine Carcinoma of Lung | Phase 1 | Not yet recruiting | Memorial Sloan Kettering Cancer Center | 12 | 2026-09-01 | 2026-08-06 |
| A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer Stereotactic body radiotherapy, Cemiplimab, Cemiplimab and Fianlimab - Bladder Urothelial Carcinoma | Phase 2 | Withdrawn | Memorial Sloan Kettering Cancer Center | 2026-09-01 | 2026-09-03 | |
| A Study of Stereotactic Radiosurgery (SRS) in People With Brain Cancer Having Tumor Resection Surgery Stereotactic Radiosurgery, Surgical Resection - Brain Metastasases | Not applicable | Recruiting | Memorial Sloan Kettering Cancer Center | 50 | 2026-08-28 | 2026-09-09 |
| A Study of Armored CAR T Cells in People With Cancer DLL3-SAVVYZ-IL18 CAR T cell - Neuroendocrine Cancer, Small Cell Lung Cancer | Phase 1 | Recruiting | Memorial Sloan Kettering Cancer Center | 16 | 2026-08-28 | 2026-09-02 |
| A Study of Romosozumab in People With Breast Cancer and Osteoporosis Romosozumab - Breast Cancer, Metastatic Breast Cancer (MBC) | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 25 | 2026-08-17 | 2026-08-20 |
Showing 20 of 2124. Sign in to see all of them.
Breast Neoplasms (251) · Prostatic Neoplasms (150) · Lung Neoplasms (109) · Lymphoma (104) · Neoplasms (99) · Leukemia (87) · Multiple Myeloma (86) · Ovarian Neoplasms (81) · Colorectal Neoplasms (73) · Carcinoma, Non-Small-Cell Lung (71) · Melanoma (70) · Sarcoma (67) · Lymphoma, Non-Hodgkin (64) · Brain Neoplasms (58) · Neoplasm Metastasis (56)
Surveys and Questionnaires (136) · Cyclophosphamide (86) · Cisplatin (82) · Radiotherapy (61) · Filgrastim (57) · Blood Specimen Collection (55) · Gemcitabine (46) · Etoposide (45) · Carboplatin (44) · Paclitaxel (44) · Doxorubicin (37) · Rituximab (37) · pembrolizumab (37) · Irinotecan (36) · Nivolumab (36)
United States (2072) · Canada (29) · Nigeria (10) · United Kingdom (10) · Netherlands (9) · Italy (7) · Australia (6) · Spain (6) · Germany (5) · Israel (5) · Norway (5) · Poland (5) · Puerto Rico (4) · Brazil (3) · Greece (3)
Jae Park, MD (17) · Jamie Ostroff, PhD (17) · Nancy Lee, MD (17) · Gary K. Schwartz, MD (14) · Jessica Scott, PhD (14) · Jun Mao, MD, MSCE (13) · Leonard B. Saltz, MD (13) · Michael Morris, MD (13) · Robert J. Motzer, MD (13) · Brian Kushner, MD (12) · David H. Ilson, MD, PhD (12) · Helena Yu, MD (12) · Paul Sabbatini, MD (12) · Tanya Trippett, MD (12) · Yelena Janjigian, MD (12)
PMID 23633099, PMID 38485730, PMID 41429239, PMID 22419878, PMID 25475068, PMID 26187751, PMID 31456070, PMID 31689242, PMID 32780846, PMID 33416261, PMID 34350976, PMID 34503735, PMID 34515338, PMID 35339025, PMID 37171634, PMID 37722357, PMID 38271621, PMID 38977653, PMID 40812353, PMID 41052404, PMID 10813118, PMID 11352950, PMID 11772431, PMID 11807794, PMID 12039921, PMID 12065559, PMID 12167786, PMID 12196376, PMID 12393820, PMID 12419754, PMID 12663715, PMID 12796370, PMID 12885811, PMID 12947072, PMID 14504052, PMID 14739217, PMID 15131031, PMID 15459300, PMID 15735119, PMID 16009951, PMID 16014111, PMID 16135465, PMID 16192597, PMID 16398649, PMID 16520464, PMID 16832603, PMID 17194908, PMID 17235042, PMID 17261851, PMID 17366595
P30CA008748 (61), UM1CA121947 (4), P01CA023766 (3), U10EY008057 (2), UM1CA081457 (2), 2018 (1), 2023 (1), 5UG1CA189824 (1), 5UH3AT009844 (1), K23AG048632 (1), K23DE020197 (1), K23NS091395 (1), N01CM00100 (1), N01CM62206 (1), P01CA005826 (1)